Biogen  logo

Biogen BIIB

$ 141.07 2.91%

Annual report 2024
added 02-12-2025

report update icon

Country

usaUSA

IPO year

-

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBALSPB

CEO

Mr. Michel Vounatsos

Employees in the company

7 400

Shares

146 M

Market Cap[1]

$ 20.5 B

EBITDA (LTM)

$ 2.03 B

P/E (LTM)

20.31

P/S (LTM)

2.7

EPS (LTM)

8.92

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.